Via CNBC
“One of the products involved in the process is Veeva Engage, a customer relationship management platform tailored to life sciences companies. The system offers online video conferencing and content sharing applications. Health-care professionals are using the program to connect with doctors remotely to deliver care to patients, Gassner explained.”
“The video conferencing tools for Veeva Engage is supplied by Zoom Video Communications, which Gassner is a board member of. Some of Veeva’s clients include Biogen, Eli Lilly and Gilead Sciences, three of many biotech companies in the race to develop a COVID-19 treatment. “
“’We’re offering that free to the whole industry until September. So we have more than 100,000 licenses provisioned, and the usage of that product is up 10x in just two weeks,’ he said. ‘The energy of the life sciences industry, there’s never been a better time.’”
Read the rest of CNBC’s reports on Veeva Systems’ COVID-19 reaction
MAA COVID-19 INFORMATION DISCLAIMER:
The Medical Alley Association is providing COVID-19 related information, including the “COVID-19 Resource Connect” feature on its website and summaries of laws, executive orders, and government programs that may be of interest to members, as a public service. The Medical Alley Association makes no representations, guarantees, or warranties as to the accuracy, completeness, currency, or suitability of the COVID-19 related information provided by the Medical Alley Association on its website, in newsletters, or in any other communications. The Medical Alley Association specifically disclaims any and all liability for any claims or damages that may result from providing COVID-19 related information online or in other communications or linking to third party websites or other sources of information. The Medical Alley Association makes no effort to independently verify, and does not exert editorial control over, information provided by third parties.
The Medical Alley Association does not endorse any of the products, vendors, consultants, or documentation referenced in, or connected to parties through, the COVID-19 Resource Connect feature or via this email or other communications.
